ENTITY
Biocon Ltd

Biocon Ltd (BIOS IN)

95
Analysis
Health CareIndia
Biocon Ltd., is an integrated biotechnology enterprise with a presence in biopharmaceuticals, enzymes, custom research and clinical research. The Company's pharmaceutical products include statins, immunosuppressants and anti-diabetic drugs. Biocon also manufactures specialty enzymes and new enzyme applications besides providing clinical and custom research services.
more
Refresh
12 Apr 2020 08:06

Last Week in Event SPACE: Sing Air, Toshiba, Car Inc, Metlifecare, CP All/Tesco, Posco, 58.com

Last Week in Event SPACE ... Singapore Airlines (SIA SP) rights and rights MCBs represent trading opportunities, and they represent some weird...

Logo
357 Views
Share
06 Feb 2019 11:41

Biosimilar Battlefield: The Remsima/Inflectra Warning

2019 marks an inflection point for Korean biosimilar companies Celltrion Healthcare (091990 KS), Celltrion Inc (068270 KS), and Samsung Biologics...

Share
11 Dec 2018 02:50

India Generic Drugs: US Antitrust Inquiry Widens

The US government's antitrust investigation of the generic drug industry has been quiet for more than a year and has resurfaced with a...

Share
01 Oct 2018 05:35

EM Strategy: Russia and Thailand Bullishly Inflecting; Pullback Opportunity in India

This report highlights actionable themes across the EM universe, including: bullish inflections in the Russian and Thai markets, and a pullback...

Logo
425 Views
Share
24 Apr 2018 02:32

EM Strategy: Overweight Technology, Energy, and Health Care.

EM equities remain long-term leadership despite giving up some ground over the last month to developed markets. Given the intact relative strength...

Logo
263 Views
Share
x